Targeted Probe and Educate (TPE) round one is supposed to be educational. In the 2025-2026 cycle, round-one outcomes increasingly escalate to UPIC pre-payment review when documentation patterns repeat. Here is what contractor reviewers actually examine in the six-month prognosis narrative.
What is at stake in TPE round one
TPE was designed as a three-round structure with educational outcomes between rounds. In recent cycles, round-one findings clustered around the same documentation pattern increasingly move agencies into UPIC pre-payment review faster than the published protocol would suggest. Round one is not the educational stop it once was. Round one is increasingly the decision point.
The hospice medical reviewer running TPE works from the eligibility documentation - the six-month prognosis narrative, the certification language, the supporting clinical record. Hospice medical-review denial rates have doubled since 2022. More than half of all Medicare hospices have reported undergoing more than one audit at the same time. The contractors are working faster, the methodology is sharper, and the round-one decisions stick.
Five specific things contractor reviewers examine
One - the underlying terminal diagnosis with specificity
The reviewer checks whether the six-month prognosis narrative documents the underlying terminal diagnosis with specificity that meets the Medicare hospice eligibility standard. Generic statements - patient has end-stage disease, patient is terminal due to advanced age - are not enough. The narrative needs to name the disease, the trajectory, and why this patient meets the six-month prognosis standard.
Two - LCD criteria applied where applicable
For most major disease categories the contractor has a Local Coverage Determination (LCD) with specific clinical indicators. Dementia uses FAST scoring. Cardiac uses NYHA class. End-stage pulmonary uses oxygen dependence and ABG values. The narrative should reference the LCD criteria explicitly and document the patient against those criteria. When the LCD is not referenced and the patient is not documented against the standard, the reviewer methodology defaults to whether the documentation meets the LCD on its own - and frequently concludes it does not.
Three - functional decline indicators with specificity
Functional decline is the second-most-tested element in the six-month prognosis narrative. Weight loss percentages with timeframes, performance status changes (PPS, Karnofsky), activities of daily living dependency progression. Reviewers look for specific decline markers - 5 percent weight loss over 30 days, increase in dependency on two ADLs, decrease in PPS from 60 to 40 over six weeks. Generic statements like patient is weaker do not document decline; they document an observation.
Four - symptom-based decline markers
The third element reviewers test is symptom-based decline - dyspnea, dysphagia, edema, pain progression, decreased oral intake, increased sleep, increased confusion. These should be tied to the specific terminal trajectory of the underlying disease, not listed as standalone observations. A narrative that says patient has increasing dyspnea documents a symptom. A narrative that says dyspnea has progressed from exertion-only to rest-dyspnea over four weeks in the context of end-stage CHF documents decline.
Five - comorbidities integrated into the prognosis reasoning
The narrative often lists comorbidities as separate diagnoses. The reviewer methodology tests whether each comorbidity is integrated into the six-month prognosis reasoning - how it contributes to the trajectory, why it accelerates the prognosis, why this combination of conditions supports the six-month standard. Listed comorbidities without integration are documentation; integrated comorbidities are reasoning.
What this means for IDG and certification practice
The five elements above are not abstract criteria. They are what the contractor reviewer is reading the narrative to find. The IDG and the hospice medical director should be writing each narrative with those elements as the explicit structure - not as a clinical narrative that incidentally touches on them.
That is the practical implication: the eligibility narrative is written for a clinical reader (the IDG team, the physician) but read by a medical reviewer with a different standard. The narrative needs to function for both audiences, and in this cycle the reviewer audience determines whether the documentation holds.
What round-one TPE response needs to do
When a TPE round one notice arrives, the response should not just defend the individual records sampled. It should:
- Address the specific finding pattern the round-one results identified, with concrete operational fixes (not narrative explanations).
- Document the operational change with measurable signals - audit cadence, training completion, documentation template revision, IDG process update - that round two can verify.
- Re-audit a sample of records produced after the operational change to demonstrate the pattern has shifted.
Responses that explain the round-one findings without engineering operational change are the responses that escalate. Responses engineered to close the probe at round one are the responses that do.
What this looks like in a real diagnostic
The methodology above is one of the eight sections in our day-one hospice diagnostic. The full 27-item audit covers initial certification, six-month prognosis narrative, IDG process, level-of-care decisions, recertification and face-to-face, plan of care discipline, TPE and UPIC response readiness, and quality reporting.
If you want to walk the diagnostic on your own program: the Hospice case file is here. The 27-item audit referenced above is sent as a PDF from the lead-magnet form, or as part of any discovery call. Open a case file with us if a sharper read on your eligibility defensibility would be useful.